<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>17</Volume>
				<Issue>5</Issue>
				<PubDate PubStatus="epublish">
					<Year>2016</Year>
					<Month>05</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Combination of Nimbolide and TNF--Increases Human Colon Adenocarcinoma Cell Death through JNK-mediated DR5 Up- regulation</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>2637</FirstPage>
			<LastPage>2641</LastPage>
			<ELocationID EIdType="pii">32451</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName> </FirstName>
					<LastName>Chantana</LastName>
<Affiliation>Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand</Affiliation>

</Author>
<Author>
					<FirstName>Chavi </FirstName>
					<LastName>Yenjai</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Prasert </FirstName>
					<LastName>Reubroycharoen</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Pornthip </FirstName>
					<LastName>Waiwut</LastName>
<Affiliation></Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>Tumor necrosis factor (TNF-), an inflammatory cytokine that plays an important role in the control of cell proliferation, differentiation, and apoptosis, has previously been used in anti-cancer therapy. However, the therapeutic applications of TNF- are largely limited due to its general toxicity and anti-apoptotic influence. To overcome this problem, the present study focused on the effect of active constituents isolated from a medicinal plant on TNF--induced apoptosis in human colon adenocarcinoma (HT-29) cells. Nimbolide from Azadirachta indica was evaluated for cytotoxicity by methyl tetrazolium 3-[4,5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide (MTT) assay and phase contrast microscopy. Effects on apoptotic signaling proteins were investigated using Western blot analysis. Nimbolide showed cytotoxicity against HT-29 cells that was significantly different from the control group (&lt;0.01), a concentration of 10 M significantly inducing cell death (&lt;0.01). In combination with TNF-, nimbolide significantly enhanced-induced cell death. In apoptotic pathway, nimbolide activated c-Jun N-terminal kinase (JNK) phosphorylation, BH3 interacting-domain death agonist (Bid) and up-regulated the death receptor 5 (DR5) level. In the combination group, nimbolide markedly sensitized TNF--induced JNK, Bid, caspase-3 activation and the up-regulation of DR5. Our findings overall indicate that nimbolide may enhance TNF--mediated cellular proliferation inhibition through increasing cell apoptosis of HT-29 cells by up-reglation of DR5 expression via the JNK pathway.</Abstract>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_32451_56a676c870a172828d2bdcd1e42c20de.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
